Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma

8 Jun 2022

Abstract excerpt

Background. Endocrine disruption is an important factor in the development of endometrial cancer. Expression of miR-149-3p is observed in some cancer types, while its role in uterine corpus endometrial carcinoma (UCEC) is unclear. Methods. The clinical and genomic data and prognostic information on UCEC were obtained for patients from the TCGA database. The Kruskal–Wallis test, Wilcoxon signed-rank test, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35719192
DOI: 10.1155/2022/5006123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial CarcinomaPMID 35719192Read ↗

Expression and prognosis of NR3C1 in uterine corpus endometrial carcinoma based on multiple datasetsSemantic proximity Read ↗

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysisSemantic proximity Read ↗

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial CancerSemantic proximity Read ↗

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics AnalysisSemantic proximity Read ↗

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

Research on the Diagnostic Value and Immune Microenvironment Regulatory Mechanism of FOLR3 Gene in Endometrial Cancer Based on Multi-omics Data AlgorithmsSemantic proximity Read ↗

Immune microenvironment and molecular mechanisms in endometrial cancer: implications for resistance and innovative treatmentsSemantic proximity Read ↗

Identification of the Prognostic LncRNA Biomarkers and Comprehensive Analysis of LncRNA-Mediated ceRNA Network for Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial CancerSemantic proximity Read ↗

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

COL1A1, ITGB1, THY1, and PDGFRA: key immune-related genes in uterine corpus endometrial carcinoma with prognostic and therapeutic implicationsSemantic proximity Read ↗

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.